sever
fever
thrombocytopenia
syndrom
sft
tickborn
hemorrhag
ill
caus
sever
fever
thrombocytopenia
syndrom
viru
sftsv
member
bunyavirida
famili
newli
identifi
central
northeast
china
sftsv
infect
character
fever
thrombocytopenia
leukocytopenia
multiorgan
dysfunct
produc
broad
spectrum
clinic
manifest
rang
acut
selflimit
febril
ill
variou
grade
sever
diseas
report
rate
vari
human
becom
infect
tick
bite
contact
blood
sft
patient
person
contact
pathogen
mechan
patient
sftsv
infect
least
partli
immunemedi
may
play
import
role
determin
sever
clinic
outcom
virus
hantavirus
hemorrhag
fever
viru
caus
cytokin
activ
uncontrol
releas
cytokin
observ
filoviru
infect
similar
seen
sepsi
caus
gramneg
bacteria
pathogenesi
sftsv
infect
clearli
defin
cytokin
chemokin
studi
respect
sftsv
infect
lack
present
studi
determin
concentr
tumor
necrosi
factor
tnf
transform
growth
factor
tgf
interleukin
il
interferon
ifn
protein
ip
rant
serum
sampl
sft
patient
endem
northeast
china
correl
diseas
sever
also
analyz
tcell
subgroup
possibl
role
diseas
sever
patient
gave
written
consent
particip
studi
permiss
perform
studi
given
ethic
committe
china
medic
univers
fiftyseven
patient
suspect
sftsv
infect
treat
hospit
april
novemb
test
sftsv
admiss
suspect
case
defin
one
acut
fever
pathogen
could
identifi
least
one
follow
laboratori
test
thrombocytopenia
leukocytopenia
histori
arthropod
bite
confirm
case
defin
posit
result
quantit
rtpcr
posit
result
igm
antibodi
sftsv
test
also
perform
detect
human
granulocyt
anaplasmosi
hfr
hemorrhag
fever
leptospira
salmonella
rickettsia
brucella
ebv
cytomegaloviru
hepat
b
c
e
viru
also
investig
plasma
sampl
obtain
patient
acut
phase
ill
sampl
serum
extract
immedi
frozen
serum
analysi
clinic
cours
laboratori
data
patient
record
prospect
individu
form
sever
sftsv
infect
defin
person
requir
admiss
intens
care
unit
met
least
one
follow
criteria
ard
heart
failur
liver
failur
shock
dissemin
intravascular
coagul
data
demograph
characterist
laboratori
measur
express
mean
median
addit
serum
sampl
healthi
volunt
febril
ill
preced
week
epidemiolog
link
endem
also
includ
control
blood
sampl
coat
edta
collect
patient
admiss
acut
phase
sftsv
infect
plasma
separ
centrifug
g
min
store
analyz
serum
level
rant
measur
retrospect
abc
elisa
kit
research
diagnost
minneapoli
mn
usa
accord
manufactur
instruct
mean
continu
variabl
compar
use
independentgroup
student
test
data
normal
distribut
otherwis
mannwhitney
test
use
proport
categor
variabl
compar
use
test
although
fisher
exact
test
use
data
spars
correl
assess
use
pearson
test
signific
set
p
use
twosid
comparison
result
analyz
use
spss
window
version
spss
chicago
il
usa
forti
patient
compris
sft
case
confirm
rtpcr
eight
elisa
admit
hilli
area
northeastern
china
six
die
mean
age
patient
year
rang
year
femal
tabl
fever
fatigu
anorexia
diarrhea
nausea
myalgia
frequent
symptom
patient
major
clinic
symptom
critic
case
disturb
conscious
arrhythmia
pancreat
seriou
pneumonia
capillari
leakag
hypotens
shock
addit
fever
thrombocytopenia
leukopenia
hemorrhagicfeverlik
symptom
also
observ
patient
patient
suffer
fever
cours
diseas
median
interv
onset
ill
day
serum
sampl
obtain
admiss
day
rang
day
mean
length
hospit
stay
day
rang
day
six
patient
die
acut
left
ventricular
failur
multiorgan
dysfunct
aplast
anemia
within
day
admiss
remain
patient
surviv
nine
patient
met
criteria
sever
diseas
pleural
pericardi
effus
observ
eight
three
patient
respect
signific
differ
interv
onset
admiss
sever
nonsever
case
median
vs
day
respect
p
tabl
howev
age
sex
ratio
durat
fever
length
hospit
stay
similar
sever
case
sftsv
infect
nonsever
infect
p
apart
patient
die
aplast
anemia
coexist
hypertens
coronari
heart
diseas
patient
sever
diseas
evid
preexist
comorbid
patient
thrombocytopenia
elev
aspart
aminotransferas
ast
alanin
aminotransferas
alt
lactat
dehydrogenas
ldh
level
clinic
laboratori
paramet
test
creactiv
protein
crp
creatinin
phosphokinas
ck
ldh
level
significantli
higher
platelet
count
calcium
albumin
level
significantli
lower
patient
sever
sftsv
infect
compar
nonsever
infect
tabl
serum
level
rant
admiss
shown
tabl
figur
figur
level
rant
significantli
higher
patient
level
significantli
lower
patient
healthi
individu
level
patient
sever
nonsever
sftsv
infect
compar
median
level
pgml
rang
pgml
pgml
rang
pgml
patient
sever
nonsever
sftsv
infect
respect
differ
signific
p
median
level
pgml
rang
pgml
pgml
rang
pgml
patient
sever
nonsever
sftsv
infect
respect
differ
signific
p
median
level
pgml
rang
pgml
pgml
rang
pgml
patient
sever
nonsever
sftsv
infect
respect
differ
signific
p
level
patient
pneumonia
n
significantli
higher
patient
without
pneumonia
n
p
signific
differ
rant
level
patient
sever
nonsever
sftsv
infect
level
nonsever
case
significantli
lower
p
valu
detect
healthi
individu
although
level
sever
case
higher
healthi
individu
differ
signific
median
vs
pgml
respect
p
level
sever
case
significantli
higher
p
healthi
individu
data
shown
count
cell
shown
decreas
differ
lymphocyt
subgroup
statist
signific
sever
nonsever
case
data
shown
correl
clinic
laboratori
paramet
cytokin
chemokin
analyz
leukocyt
lymphocyt
count
posit
correl
level
posit
correl
level
observ
figur
present
cytokin
profil
follow
sftsv
infect
hospit
patient
interv
onset
admiss
significantli
longer
sever
case
nonsever
case
may
risk
factor
sever
sftsv
infect
laboratori
find
includ
higher
level
crp
ldh
ck
lower
level
albumin
platelet
count
serum
calcium
sever
case
date
pathogenesi
sftsv
infect
clearli
defin
inflammatori
cytokin
chemokin
first
ramif
activ
innat
immun
cell
play
role
pathogenesi
viru
infect
anim
human
also
suggest
besid
high
level
viral
replic
immunolog
respons
might
contribut
diseas
pathogenesi
sftsv
infect
prospect
studi
strike
phenomenon
signific
increas
plasma
rant
signific
decreas
plasma
patient
sftsv
infect
increas
level
relat
sever
ill
data
togeth
signific
correl
found
level
suggest
intens
inflammatori
respons
viru
infect
perhap
specif
involv
recruit
inflammatori
cell
infect
tissu
contribut
diseas
pathogenesi
markedli
elev
level
also
correl
fatal
ebola
viru
infect
also
correl
sever
hemorrhag
fever
renal
syndrom
hfr
pleural
pericardi
effus
hemorrhagicfeverlik
symptom
commonli
observ
patient
sftsv
infect
howev
pathogenesi
vascular
leakag
known
viral
factor
target
endothelium
directli
indirectli
virusmedi
hostderiv
solubl
factor
caus
endotheli
activ
dysfunct
indirectli
produc
monocyt
macrophag
cell
act
endothelium
stimul
product
vasodil
substanc
induc
synthas
import
effect
capillari
endotheli
permeabl
synergist
effect
endotheli
cell
cultur
vitro
increas
monolay
permeabl
might
play
role
capillari
leakag
whether
role
sftsv
infect
viral
hemorrhag
fever
known
one
main
proinflammatori
protein
also
involv
induct
acut
inflammatori
respons
level
cytokin
blood
sftsvinfect
patient
also
associ
clinic
outcom
present
studi
level
shown
increas
patient
especi
fatal
case
also
predict
factor
diseas
sever
dengu
patient
major
function
activ
macrophag
differenti
helper
th
cell
inhibit
pathway
control
intracellular
pathogen
play
major
role
host
defens
mechan
includ
immun
respons
acutephas
reaction
hematopoiesi
present
studi
level
associ
sever
ill
level
sever
case
markedli
elev
compar
nonsever
case
contrast
express
nonsever
case
suppress
suggest
may
lead
diseas
progress
also
report
signific
associ
high
ill
sever
phenotyp
allel
patient
acut
infect
viru
ebv
coxiella
burnetii
ross
river
viru
caus
significantli
lower
level
nonsever
case
sftsv
infect
yet
known
chemokin
synergist
induc
variou
cell
type
type
ii
ifn
lipopolysaccharid
cytokin
tolllik
receptor
ligand
chemoattract
recruit
natur
killer
activ
cell
site
tissu
inflamm
level
patient
similar
healthi
individu
significantli
higher
level
sever
case
compar
nonsever
case
healthi
individu
potent
chemoattract
activ
lymphocyt
produc
respons
may
reflect
cell
activ
product
inflammatori
cytokin
therefor
find
suggest
sftsv
activ
mainli
immun
respons
viral
invas
significantli
elev
level
observ
patient
pneumonia
also
report
infect
influenza
viru
sever
acut
respiratori
syndrom
howev
report
express
rant
induc
hantaviru
infect
increas
permeabl
human
lung
microvascular
endotheli
cell
patient
viru
infect
might
explain
promin
macrophag
inflammatori
infiltr
lung
human
cutan
leishmaniasi
product
one
indic
sustain
cellmedi
immun
respons
mediat
expans
antigenspecif
cell
also
cell
whether
produc
cell
also
play
role
sever
patient
sftsv
infect
requir
evalu
reduc
level
nonsever
patient
may
due
inhibit
express
product
antagonist
sftsv
infect
decreas
level
nonsever
sft
patient
suggest
express
sftsv
infect
may
reflect
sever
diseas
interact
cytokin
also
demonstr
morbid
mortal
mous
model
cerebr
malaria
bacteri
sepsi
also
regul
respons
regul
interact
respons
earlyphas
cytokin
act
local
trigger
cascad
cytokin
includ
posit
correl
level
observ
patient
associ
serum
level
high
serum
creatinin
low
platelet
count
hfr
patient
report
associ
serum
level
cytokin
observ
studi
includ
high
serum
ck
creatinin
low
platelet
tcell
subgroup
cell
upregul
level
relat
increas
respons
infect
fever
phagocyt
cell
recruit
blood
vessel
permeabl
correl
serum
cytokin
chemokin
level
bodi
temperatur
observ
studi
howev
leukocyt
lymphocyt
count
posit
correl
level
figur
lymphopenia
common
sft
patient
apoptosi
lymphocyt
induc
level
shown
decreas
patient
studi
lymphopenia
occur
clearli
understood
basi
result
believ
cytokinemedi
inflammatori
respons
character
cytokin
chemokin
product
imbal
play
import
role
diseas
progress
patient
sftsv
infect
level
cytokin
correl
diseas
sever
immunolog
studi
requir
elucid
role
immun
respons
patient
outcom
